Integrated tube cap design simplifies access to medicationJuly 11, 2008Many vitamin pills and tablets such as pain killers are packaged today in cylindrical tubes with a cork-like cap. This will often incorporate some form of desiccant to protect the contents against moisture, while a simple mechanical spring in the tube stops the contents from rattling around. However, such caps often fall off, are easy to lose and require two hands to manipulate. Customers and suppliers of vitamin pills and similar drugs have been used to this conventional design for many years. The EUREKA project set out to improve the design with an innovative flap closure that could hold a desiccating powder and could be opened simply with one hand. "This was a novel idea that emerged inhouse," explains Klaus Höfflin of German project leader KUTTERER. Creating a new handling and packaging technology needed close co-operation with the pharmaceutical industry. The solution had to be demonstrated in close-to-production prototype samples.
KUTTERER worked on the design with Austrian injection moulding tool manufacturer KTWKunststofftechnik. "We could have done the project ourselves but it would have taken longer and cost more," says Höfflin. "KTW is our main mould supplier. We know what they do and their capabilities, making it easy for us to work together. EUREKA labelling helped us obtain the funding to go ahead with the project." The resulting one-piece low density polyethylene moulding is easy to open and close with one hand, stays connected to the container to avoid its loss and preclude contamination of the contents, integrates a dessicator chamber to prevent the contents becoming damp, incorporates a tamperproof seal and includes a spring that holds the tablets in place before use. Markets are expected in high-value pharmaceuticals. The design enables high-volume production with the estimated capacity of one injection mould at least 20 million pieces a year. "This is a new product segment we hope to develop," says Höfflin. "Customers have been convinced by the prototypes. Development is now continuing to put the new design into full production within two or three years." EUREKA | |||||||||||||||||||||
|
Related Medication Current Events and Medication News Articles Takeda's investigational PPI TAK-390MR demonstrated higher healing rates compared to lansoprazole Combined results from two Phase 3 studies presented at the American College of Gastroenterology Annual Scientific Meeting (ACG) in Orlando, Fla., demonstrated that TAK-390MR resulted in higher healing rates than lansoprazole among patients with more severe grades of erosive esophagitis (EE). Major study of opiate use in children's hospitals provides simple steps to alleviate harm Hospitalized kids with painful ailments from broken bones to cancer are often dosed with strong, painkilling drugs known as opiates. New test could help catch serious infections in babies A simple blood test may help detect serious bacterial infections (SBIs) like urinary tract infections and blood stream infections in young infants who come to the emergency department (ED) with fevers that have no clear cause. Children's asthma affected by parental expectations Asthmatic children whose parents have high expectations for their ability to function normally are less likely to have symptoms than other children dealing with the condition, according to a new study. Vitamin D deficiency common in patients with IBD, chronic liver disease New research presented at the 73rd Annual Scientific Meeting of the American College of Gastroenterology in Orlando found patients with inflammatory bowel disease or chronic liver disease were at increased risk of developing Vitamin D deficiencies. Two separate studies highlight the importance of regular Vitamin D checkups in the evaluation of patients with certain digestive diseases. Millisecond brain signals predict response to fast-acting antidepressant Images of the brain's fastest signals reveal an electromagnetic marker that predicts a patient's response to a fast-acting antidepressant, researchers have discovered. Genes influence effectiveness of weight-loss drug Obese patients with a specific genetic make-up lose more weight when taking the weight loss drug sibutramine and undergoing behavioral therapy compared to those without this genetic make-up, reports a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. Getting help for depression and anxiety has significant long-term benefits According to the Mood Disorder Society of Canada, about 1.3 million Canadians suffer from depression. HIV drug maraviroc effective for drug-resistant patients As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death. UNC project helps students with mental illnesses, support services prepare for 'what if' scenarios Nationally, an estimated 15 percent of students experience some form of mental illness such as major depression while in college. Many often struggle with where to get support. More Medication Current Events and Medication News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||